Athyrium Capital Management LP

Athyrium Capital Management LP is a distinguished New York-based asset management firm exclusively dedicated to investment opportunities within the global healthcare sector. Established with a clear focus, the firm manages significant capital for a diverse base of institutional investors, including endowments, foundations, pension funds, and family offices. Athyrium distinguishes itself through its deep industry expertise and a flexible investment approach, aiming to provide capital solutions across various stages of healthcare companies.

The firm's investment strategy is comprehensive, spanning a wide array of healthcare sub-sectors such as biopharmaceuticals, medical devices, diagnostics, healthcare services, and digital health. Athyrium employs a multi-faceted investment toolkit, which includes growth equity, structured debt, and royalty stream financing. This versatility allows them to tailor solutions to the specific needs of portfolio companies, from supporting product development and commercialization to facilitating strategic acquisitions and recapitalizations.

Athyrium has demonstrated a robust fundraising track record, underscoring investor confidence in its specialized strategy. For instance, Athyrium Opportunities Fund V successfully closed in 2021 with $2.0 billion in committed capital, following its predecessor, Athyrium Opportunities Fund IV, which also closed at $2.0 billion in 2018. This consistent ability to raise substantial funds reflects their capacity to deploy significant capital into promising healthcare ventures. Overall, the firm manages over $5 billion in committed capital, positioning it as a major player in healthcare-focused private investments. Their typical investment sizes align with their fund scale, often ranging from tens of millions to several hundred million dollars, reflecting their focus on providing substantial capital for growth and strategic initiatives within the healthcare ecosystem.